Med City firm in a race to find unvaccinated patients for trial
Imanis Life Sciences, based on the Rochester Technology (former IBM) Campus, is urgently seeking 100 people with blood without COVID-19 antibodies for clinical trial. The number of potential participants dwindles each day as more and more people become vaccinated. 3:29 pm, Apr. 15, 2021 ×
Principal scientist Rianna Vandergaast demonstrates how plate readers measure luminescence for antibody testing on Tuesday, December 8, 2020, at Imanius Life Sciences in northwest Rochester. (Traci Westcott / twestcott@postbulletin.com)
Rochester’s Imanis Life Sciences is in “a foot race” to recruit blood donors who haven’t had COVID-19 or been vaccinated for a clinical trial to improve the efficiency of its immunity test.